Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Researchers in Canada are reprogramming blood cells into insulin-producing cells to overcome the challenges of islet transplantation with the aim of eliminating the need for people living with type 1 diabetes to take insulin injections.
A new blood cell transplant technique is being worked on, that, if successful, would bypass the need for anti-rejection drugs and possibly keep people living with type 1 diabetes to require lifelong insulin injections.
Researchers at the University of Alberta in Canada are hard at work on what they hope will become the next big diabetes breakthrough.
Next year will mark the 100th anniversary since the discovery of insulin.
Previously DRWF-funded researcher Professor James Shapiro, Professor of Surgery in the Faculty of Medicine & Dentistry and Canada Research Chair in Transplantation Surgery and Regenerative Medicine, whose research led to the ground-breaking Edmonton Protocol for islet cell transplants to treat diabetes, is leading the study.
A new blood cell transplant technique is being worked on, that, if successful, would bypass the need for anti-rejection drugs and possibly keep people living with type 1 diabetes to require lifelong insulin injections.
Researchers at the University of Alberta in Canada are hard at work on what they hope will become the next big diabetes breakthrough.
Next year will mark the 100th anniversary since the discovery of insulin.
Previously DRWF-funded researcher Professor James Shapiro, Professor of Surgery in the Faculty of Medicine & Dentistry and Canada Research Chair in Transplantation Surgery and Regenerative Medicine, whose research led to the ground-breaking Edmonton Protocol for islet cell transplants to treat diabetes, is leading the study.
